Skip to main content
. 2015 Mar;12(2):165–173. doi: 10.11909/j.issn.1671-5411.2015.02.011

Table 1. Mean age of patients in land mark heart failure trials.[54].

Trial Year Study treatment No. of patients Mean age in years (approximate)
SOLVD* 1991 Enalapril 2569 61
DIG (main trial) 1997 Digoxin 6800 63
RALES 1999 Spironolactone 1663 65
CIBIS II* 1999 Bisoprolol 2647 61
ATLAS 1999 Low-dose vs. high-dose lisinopril 3793 64
COPERNICUS 2001 Carvedilol 2289 63
BEST 2001 Bucindolol 2706 60
EPHESUS 2001 Eplerenone 6632 64
Val-HeFT 2002 Valsartan 5010 65
MADIT II 2002 ICD 1232 64
COMET 2003 Carvedilol vs. metoprolol 3029 62
CARE HF 2005 CRT vs. medical therapy alone 813 67
MADIT-CRT 2009 CRT-defibrillator vs. ICD 1820 65
SHIFT 2010 Ivabradine 6558 60
EMPHASIS 2011 Eplerenone 2737 69

*SOLVD and CIBIS II had age < 80 years in the inclusion criteria. CRT: cardiac resynchronization therapy; ICD: internal cardioverter defibrillator;